Processa Pharmaceuticals, Inc. company info

CIK 1533743
IRS Number 451539785
State of incorporation DE
Business address 7380 COCA COLA DRIVE
Mail address 7380 COCA COLA DRIVE

Short summary

Processa Pharmaceuticals, Inc. is a Maryland company, with head office located at 7380 Coca Cola Drive Hanover, Maryland 21076. In 2019 the company owned a total of 10.01 million USD worth of assets, including 356.52 thousand USD worth of current assets. 2017 was the year when the company amassed the most assets.

Processa Pharmaceuticals, Inc. Income Statement

Name [in Millions USD]201120122013201420152016201720182019Trends
Revenue, Net
Gross Profit
Selling, General and Administrative Expense 1.882.822.840.950.070.841.44
Research and development 0.450.
Operating Expenses 2.333.094.252.680.081.80
Operating Income (Loss) -1.92-1.80-4.52-3.94
Interest expense -0.17-0.110.320.
Income Tax Expense (Benefit) -0.00-0.00-0.00-0.00-0.90-0.60
Net income -2.44-3.07-4.53-3.35-1.92-1.86-3.77-3.36

Processa Pharmaceuticals, Inc. Balance Sheet

Name [in Millions USD]201120122013201420152016201720182019Trends
Cash and cash equivalents 2.130.630.
Deferred income taxes 3.414.945.07
Property, Plant and Equipment, Gross 0.340.570.640.
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment -0.05-0.13-0.24-
Intangible Assets, Net (Excluding Goodwill) 10.8210.049.44
Other Assets, Noncurrent 0.0110.8210.309.65
Total assets 3.472.780.880.040.0014.4411.3110.01
Current assets 0.940.470.480.040.003.590.990.36
Accounts payable
Taxes Payable, Current
Total current liabilities 2.360.562.092.212.490.650.781.25
Long-term Debt 0.03
Deferred income taxes 2.481.831.69
Total liabilities 2.462.
Common Stock, Value, Issued
Retained Earnings (Accumulated Deficit) -5.03-9.13-15.62-15.07-15.39-6.16-9.34-11.86

Processa Pharmaceuticals, Inc. Cash Flow

Name [in Millions USD]201120122013201420152016201720182019Trends
Net income -2.44-3.07-4.53-3.35-1.92-1.86-3.77-3.36
Amortization of Intangible Assets 0.360.360.180.620.80
Deferred Income Tax Expense (Benefit) -0.17-1.23-0.60
Inventories -0.05-0.10-0.07-0.01
Accounts payable
Deferred revenue 0.06-0.06
Net Cash Provided by (Used in) Operating Activities -1.89-2.54-2.69-0.87-0.04-1.65-3.71-2.75
Payments to Acquire Property, Plant, and Equipment 0.330.
Payments to Acquire Intangible Assets 0.02
Net Cash Provided by (Used in) Investing Activities -0.33-0.03-0.040.04-1.041.00-0.02
Net Cash Provided by (Used in) Investing Activities, Continuing Operations -
Proceeds from Issuance of Common Stock 0.370.094.272.87
Net Cash Provided by (Used in) Financing Activities 0.451.732.570.824.272.432.621.70
Cash and Cash Equivalents, Period Increase (Decrease) -1.77-0.83-0.17-0.01-0.011.78-1.11